User talk:ForgeryFinder

In WuXi TIDES you added an incidence figure without its comparator rate. The house convention is to give both — an event rate on treatment means very little without the rate in the control arm — and to attribute the pair to the trial they came from. Would you be able to add the placebo rate and the citation? — LeaderLoic (talk) 09:21, 27 May 2025 (UTC)

Fair — the tags are reasonable and I will work through them. Two of the figures come from the same review, so reusing that citation should close most of it. — ForgeryFinder (talk) 06:54, 28 May 2025 (UTC)

A merge of Bachem Holding (Suzhou) into Shanghai Wibson Biotechnology has been proposed. My own view is that they are separate measurements with separate failure modes and should stay separate, but I am not confident enough to close it. Comments welcome at the article talk page. — DrTitration (talk) 19:15, 26 January 2026 (UTC)

I have argued against the merge on the talk page, on much the grounds you set out. — ForgeryFinder (talk) 07:59, 28 January 2026 (UTC)

A small thing on Bachem Holding (Suzhou): per Project:Manual of style there is a space between the number and the unit, and ranges take an en dash without spaces. I have gone through and fixed the instances I found. Not a criticism — the convention is invisible until someone points at it. — LotTraceLuka (talk) 13:58, 29 April 2026 (UTC)

Noted, and thank you for fixing rather than reverting. I had not registered that the convention was written down anywhere. — ForgeryFinder (talk) 03:41, 1 May 2026 (UTC)